TaiMed Biologics (4147) is pleased to announce its invitation to participate in the 2025 Taiwan Biotech Industry Summit Forum, jointly organized by the Taipei Exchange (OTC) and Yuanta Securities. The forum will be grandly held on July 24 and 25, 2025, on the 5th floor of Hall 1 at the Taipei Nangang Exhibition Center.

Dr. Jimmy Chang, CEO of TaiMed Biologics, will deliver a presentation on Thursday, July 24, from 4:10 PM to 4:50 PM, sharing the company’s latest progress and forward-looking strategies in the development of innovative long-acting HIV antibody therapies and its groundbreaking ADC platform and opportunities. He will also offer insights and practical perspectives on the future trends of the biotech and pharmaceutical industries and strategies for international collaboration.

“We are honored to be invited to this important forum, which provides a valuable opportunity for in-depth exchange with industry peers, investors, and policymakers,”said Dr. Jimmy Chang. “TaiMed Biologics remains committed to innovation-driven R&D and to advancing the global competitiveness of Taiwan’s biotech industry.”

The forum brings together leading biotech and pharmaceutical companies in Taiwan to explore future industry trends and capital market strategies, injecting fresh perspectives and momentum into the Taiwanese biotech sector.